<DOC>
	<DOCNO>NCT00534001</DOCNO>
	<brief_summary>RATIONALE : Bupropion may help people stop smoke decrease symptom nicotine withdrawal . Giving bupropion longer period time may effective help people stop smoking . PURPOSE : This randomized phase II trial study well bupropion work help adult stop smoking .</brief_summary>
	<brief_title>Bupropion Helping Adults Stop Smoking</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine feasibility conduct full-scale clinical trial evaluate whether extend duration pre-cessation bupropion hydrochloride enhance smoke cessation , measure 3-month prolonged abstinence rate , adult smoker . Secondary - Assess baseline smoke mood characteristic ( nicotine dependence , smoke history , anxiety , depression ) . - Assess measure address hypothesize extinction mechanism ( subjective effect smoke , collection cigarette butt assessment nicotine tar exposure , crave smoking , expectation consequence smoke ) . - Assess change affective state measure Withdrawal Symptoms Checklist Positive Negative Affect Schedule ( PANAS ) questionnaire . - Assess side effect , pill count , change daily smoke rate . - Assess mental health , personality trait , interpersonal skill , demand simulation , impulsivity , motivation , perceive stress use validated measure . OUTLINE : Participants stratify accord gender . Participants randomize 1 2 pre-cessation intervention arm . - Arm I ( 1-week run-in ) : Participants receive oral placebo twice daily week 1-3 follow oral bupropion hydrochloride twice daily week 4 . Participants also undergo 90-minute behavioral group counsel session week 1 , 2 , 4 . - Arm II ( 4-week run-in ) : Participants receive oral bupropion hydrochloride twice daily week 1-4 . Participants also undergo 90-minute behavioral group counsel session week 1 , 2 , 4 . In arm , participant ask quit smoking ( target quit date ) week 5 . All participant receive oral bupropion hydrochloride twice daily week 5-11 undergo 90-minute behavioral group counsel session week 5 , 7 , 9 . Participants complete questionnaire collect information tobacco use history , health habit , depression , anxiety scales/symptoms , sociodemographics baseline . Participants also complete series validate questionnaire smoke pattern , smoke satisfaction , mental health , personality trait , interpersonal skill , demand simulation , impulsivity , motivation , perceive stress baseline periodically study . Participants undergo saliva sample collection baseline periodically study . Samples analyze presence cotinine . Buccal cell also collect baseline subsequent DNA analysis . Cigarette butt first cigarette day , include quit day , collect group counsel session week 1 , 2 , 4 , 5 assess marker indicate amount nicotine tar consume . After finish study treatment , participant follow 6 12 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Currently smoke â‰¥ 15 cigarette per day least 1 year Motivated quit smoking within next 3 month PATIENT CHARACTERISTICS : Willing attend clinic visit Willing refrain nicotine replacement therapy ( NRT ) use study participation Able speak read English fluently Has home telephone plan reside Western New York next year Not pregnant nursing Negative pregnancy test Not plan pregnancy Fertile patient must use effective contraception 3 month study participation No history chronic renal hepatic disease No history head trauma seizure No history seizure disorder , brain tumor , CNS tumor No history currently diagnose bulimia anorexia nervosa No history psychotic disorder No diabetes require oral hypoglycemics insulin No excessive use alcohol alcoholism No current addiction opiate , cocaine , stimulants No poorly control hypertension ( i.e. , systolic blood pressure [ BP ] &gt; 170 mm Hg and/or diastolic BP &gt; 110 mm Hg ) No allergy bupropion hydrochloride No surgical medical condition may significantly alter absorption , distribution , metabolism , excretion bupropion hydrochloride No history noncompliance medical regimens No clinical contraindication No major depressive disorder PRIOR CONCURRENT THERAPY : At least 14 day since prior concurrent monoamine oxidase inhibitor No recent discontinuation benzodiazepine No concurrent Hypericum perforatum ( St. John 's wort ) No concurrent drug contain bupropion hydrochloride ( e.g. , Wellbutrin Zyban ) No concurrent antipsychotic , antidepressant , theophylline , systemic steroid , overthecounter stimulant anorectic , levodopa No concurrent active treatment cancer ( e.g. , chemotherapy radiotherapy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>bladder cancer</keyword>
	<keyword>cervical cancer</keyword>
	<keyword>esophageal cancer</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>renal cell carcinoma</keyword>
	<keyword>adult primary liver cancer</keyword>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>small cell lung cancer</keyword>
	<keyword>pancreatic cancer</keyword>
	<keyword>hypopharyngeal cancer</keyword>
	<keyword>laryngeal cancer</keyword>
	<keyword>lip oral cavity cancer</keyword>
	<keyword>nasopharyngeal cancer</keyword>
	<keyword>oropharyngeal cancer</keyword>
	<keyword>paranasal sinus nasal cavity cancer</keyword>
	<keyword>adult acute myeloid leukemia</keyword>
	<keyword>tobacco use disorder</keyword>
</DOC>